While COVID-19 has impacted the health of the world’s population, how has it changed the healthcare industry’s M&A landscape? Traditionally, healthcare has seen very high levels of global activity, with $31.62 billion in aggregate transaction value during the first half of 2020.
Will these levels hold for the remainder of 2020 into 2021? Could the recent stress on systems and economies spur even more M&A activity?
Hear from dealmakers tracking the managed care, care delivery and tech, and digital health segments.
